Skip to main content
Clinical Trials/IRCT201108286808N2
IRCT201108286808N2
Completed
Phase 3

Comparison effects of Progesterone by vaginal suppository and betamimetics to reduce preterm birth in women at risk

Birjand University of Medical Science0 sites56 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Preterm delivery.
Sponsor
Birjand University of Medical Science
Enrollment
56
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Birjand University of Medical Science

Eligibility Criteria

Inclusion Criteria

  • cervical insufficiency, history of premature labor and uterine abnormalities.
  • Exclusion criteria :
  • fetal abnormalities, preeclampsia, and sensitivity to progesterone

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials